Absolutely.
There has been for example, I don't remember which.... It's produced by Apotex, the cost is something like 10 times more in Canada than in New Zealand, but it is Apotex selling the same drug in New Zealand as well.
The way we price generic drugs is politically decided. It should be based on the price of brand-name drugs while there is market competition. This is kind of nonsense. We're paying way too much for generics as well.
The fact that the generic sector and the brand-name sector can live with the agreement, I can absolutely understand. The generics were expecting something much worse in terms of what it would mean for them in terms of being competitive with the brand-name drugs. In the end it wasn't so bad. In the brand-name sector I completely understand that they can live with that as well because basically it is more earnings without anything in compensation.
In terms of Canadian citizens, I think it is basically a bad agreement. I think in the end it increases costs without providing anything back to Canadian citizens.